HomeCompany NewsUS FDA approves Urogen's bladder cancer drug Company NewsHealthIsraelMiddle EastN2:BIODRGN2:CNCERN2:HECAN2:MEDREGN2:MRCHN2:PHMRN2:PUBLsubj:04002006subj:04016000subj:07000000subj:07001004subj:07013000subj:13019000 US FDA approves Urogen’s bladder cancer drug June 12, 2025 0 67 Share FacebookTwitterPinterestWhatsApp Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration has approved Urogen Pharma's drug to treat a type of bladder cancer, the regulator said on Thursday. (Reporting by Padmanabhan Ananthan and Kamal Choudhury in Bengaluru; Editing by Leroy Leo) Hi, I'm Reuters Share FacebookTwitterPinterestWhatsApp Previous articleUS sues New York over law blocking immigration enforcement near courtNext articleTunisia sentences prominent opposition figure Abir Moussi to two years in prison RELATED ARTICLES America Person of interest detained in fatal mass shooting at Brown University December 15, 2025 America Hong Kong’s legal clampdown on Jimmy Lai, tycoon and China critic December 15, 2025 Asia Hong Kong tycoon Jimmy Lai found guilty of collusion with foreign forces December 15, 2025 Most Popular Beachside shooting throws Australia’s gun control regime into question December 15, 2025 Ex-South Korea President Yoon tried to provoke Pyongyang into armed aggression, prosecutor says December 15, 2025 Hong Kong court finds tycoon Jimmy Lai guilty in landmark security trial December 15, 2025 Person of interest detained in fatal mass shooting at Brown University December 15, 2025 Reaction to Hong Kong tycoon Jimmy Lai’s guilty verdict in national security trial December 15, 2025 Hong Kong’s legal clampdown on Jimmy Lai, tycoon and China critic December 15, 2025 Load more